Left ventricular end-diastolic volume as an early indicator of Trastuzumab-related cardiotoxicity in patients with HER2 positive breast cancer: results from a single-center retrospective study
4D deformation, arterial stiffness, and cardiac biomarkers for the early detection of chemotherapy-induced cardiotoxicity in patients with nonHodgkin lymphoma